GZR4 injection

DRUG4 trials

Sponsors

Gan and Lee Pharmaceuticals, USA, Gan & Lee Pharmaceuticals.

Conditions

Diabetes Mellitus, Type 2Healthy SubjectsType 2 Diabetes

Phase 1

A Study of GZR4 Injection at Different Injection Sites

RecruitingNCT06548906

Gan and Lee Pharmaceuticals, USAHealthy Subjects

Start: 2024-05-08End: 2024-08-31Target: 24Updated: 2024-08-12

A Phase I Study to Evaluate the PK and PD Profiles of GZR102 Injection Versus GZR4 Injection and GZR18 Injection Given Separately in Chinese Adult Overweight Subjects

Not yet recruitingNCT06974487

Gan & Lee Pharmaceuticals.Type 2 Diabetes

Start: 2025-05-08End: 2025-09-30Target: 30Updated: 2025-05-16

Comparison Study of Insulin GZR4 With Insulin Degludec

RecruitingNCT07146347

Gan and Lee Pharmaceuticals, USAType 2 Diabetes

Start: 2025-08-15End: 2026-06-01Target: 14Updated: 2025-08-28

Phase 2

A Trial Comparing the Efficacy and Safety of GZR4 Injection Versus Insulin Degludec in Subjects with Type 2 Diabetes Mellitus

CompletedNCT06202079

Gan and Lee Pharmaceuticals, USADiabetes Mellitus, Type 2

Start: 2023-08-11End: 2024-08-08Updated: 2025-01-23